Trevi Therapeutics Inc (TRVI)
Healthcare
Biotechnology
18.30 $
-0.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Trevi Therapeutics Inc (TRVI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -17 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.9 | -7.3 | -6.4 | -10 | -8.7 | -9.6 | -9.6 | -13 | -10 | -11 | -7.6 | -17 | -45 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.6 | 0.5 | 0.5 | 0.7 | 1.1 | 0.8 | 0.9 | 1.2 | 1.4 | 1.2 | 1.4 | 2.2 | 6.2 | |
| 0.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -3.0 | 0.2 | 0.7 | -0.1 | 2.7 | 3.2 | 1.0 | -4.1 | 1.1 | -0.2 | -0.3 | -5.4 | -4.8 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13 | 0.0 | 0.0 | 13 | 0.1 | 14 | |
| 20 | 18 | 13 | -8.1 | 2.8 | 7.7 | -24 | -10.0 | -2.6 | -51 | -31 | 17 | -67 | |
| -7.7 | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -7.7 | 1.5 | -0.1 | 0.0 | 5.1 | 5.0 | 51 | 8.7 | 110 | 1.6 | 0.3 | 0.2 | 113 | |
| 2.1 | 12 | 6.4 | -19 | -0.8 | 3.1 | 18 | -15 | 98 | -60 | -38 | 0.5 | 0.0 | |
| -9.9 | -7.3 | -6.4 | -10 | -8.7 | -9.6 | -9.6 | -13 | -10 | -11 | 5.8 | -17 | -32 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.